Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 3
2006 1
2007 2
2008 1
2010 1
2011 1
2012 1
2013 2
2014 4
2015 1
2016 1
2017 3
2018 1
2019 1
2020 5
2021 12
2022 7
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study.
Inatani M, Orii Y, Iwasaki K, Arimura S, Sunagawa H, Shiokawa M, Inoue K, Sakono T, Sakono T, Kuwamura R, Yoshida A, Oi J, Kuwayama Y, Kano K, Kido N, Matsuyama A, Ozaki M, Abe H, Inoue C, Nakagawa S, Musashi K, Kanamori A, Lee J, Otani S, Aoki R, Tanabe H, Nakakura S, Suzuki K, Sagara T, Saito Y, Sameshima M, Urahashi M, Watanabe-Kitamura F, Inoue T, Kagaya F, Murai Y, Mori S, Ueda K, Kurimoto T, Yamada-Nakanishi Y, Nakamura M, Yamashita T, Ishiyama S, Manabe S, Takaki K, Hayashi K, Ishida A, Tsutsui A, Manabe K, Tanito M. Inatani M, et al. Among authors: ishida a. Adv Ther. 2023 Sep;40(9):4074-4092. doi: 10.1007/s12325-023-02589-9. Epub 2023 Jul 15. Adv Ther. 2023. PMID: 37452961 Free PMC article. Clinical Trial.
Blocking the FSTL1-DIP2A Axis Improves Anti-tumor Immunity.
Kudo-Saito C, Ishida A, Shouya Y, Teramoto K, Igarashi T, Kon R, Saito K, Awada C, Ogiwara Y, Toyoura M. Kudo-Saito C, et al. Among authors: ishida a. Cell Rep. 2018 Aug 14;24(7):1790-1801. doi: 10.1016/j.celrep.2018.07.043. Cell Rep. 2018. PMID: 30110636 Free article.
Challenges in the diagnosis of the enigmatic primary adrenal leiomyosarcoma: two case reports and review of the literature.
Suzuki S, Takahashi N, Sugo M, Ishiwata K, Ishida A, Watanabe S, Igarashi K, Ruike Y, Naito K, Fujimoto M, Koide H, Imamura Y, Sakamoto S, Ichikawa T, Kubota Y, Wada T, Yamazaki Y, Sasano H, Ikeda JI, Tatsuno I, Yokote K. Suzuki S, et al. Among authors: ishida a. BMC Endocr Disord. 2023 Dec 18;23(1):276. doi: 10.1186/s12902-023-01530-z. BMC Endocr Disord. 2023. PMID: 38110958 Free PMC article. Review.
Antihypertensive Effects of Esaxerenone in Older Patients with Primary Aldosteronism.
Fujimoto M, Watanabe S, Igarashi K, Ruike Y, Ishiwata K, Naito K, Ishida A, Koshizaka M, Suzuki S, Shiko Y, Koide H, Yokote K. Fujimoto M, et al. Among authors: ishida a. Int J Hypertens. 2023 Jan 17;2023:6453933. doi: 10.1155/2023/6453933. eCollection 2023. Int J Hypertens. 2023. PMID: 36704237 Free PMC article.
Hallermann-Streiff syndrome diagnosed in the seventh decade of life.
Shimada A, Takayanagi Y, Ichioka S, Ishida A, Tanito M. Shimada A, et al. Among authors: ishida a. Am J Ophthalmol Case Rep. 2022 May 25;27:101595. doi: 10.1016/j.ajoc.2022.101595. eCollection 2022 Sep. Am J Ophthalmol Case Rep. 2022. PMID: 35651595 Free PMC article.
Characteristics of benign adrenocortical adenomas with 18F-FDG PET accumulation.
Ishiwata K, Suzuki S, Igarashi K, Ruike Y, Naito K, Ishida A, Deguchi-Horiuchi H, Fujimoto M, Koide H, Imamura Y, Sakamoto S, Ichikawa T, Ikeda JI, Yokote K. Ishiwata K, et al. Among authors: ishida a. Eur J Endocrinol. 2021 Jun 5;185(1):155-165. doi: 10.1530/EJE-20-1459. Eur J Endocrinol. 2021. PMID: 33960957
54 results